Prana Enrolls First Patient in the “Reach2HD” Phase II Huntington Disease Trial July 17, 2013August 16, 2022
Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference March 10, 2021August 16, 2022